1974
DOI: 10.1080/00039896.1974.10666604
|View full text |Cite
|
Sign up to set email alerts
|

Safety Evaluation in the Home of Polyvinyl Chloride Resin Strip Containing Dichlorvos (DDVP)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1977
1977
2012
2012

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…For example, Zavon and Kindel (1966) found no significant inhibition of RBC or plasma cholinesterase (measured monthly) at any timepoint following human volunteer inhalation exposures to DDVP emanating from resin vaporizers for up to 6 months in their homes. In another study, no significant inhibition of RBC cholinesterase was reported in individuals following 12 months of exposure to DDVP resin strips used throughout homes (Leary et al, 1974).…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…For example, Zavon and Kindel (1966) found no significant inhibition of RBC or plasma cholinesterase (measured monthly) at any timepoint following human volunteer inhalation exposures to DDVP emanating from resin vaporizers for up to 6 months in their homes. In another study, no significant inhibition of RBC cholinesterase was reported in individuals following 12 months of exposure to DDVP resin strips used throughout homes (Leary et al, 1974).…”
Section: Discussionmentioning
confidence: 97%
“…Inhibition of RBC cholinesterase even at levels as high as 50% are not routinely accompanied by signs of toxicity (Gallo and Lawryk, 1991). RBC cholinesterase inhibition has been frequently used to establish safe exposure levels Leary et al (1974) Infants, children, adult and elderly males and females Inhalation Gratz et al (1963) Infants, children, adult and elderly males and females Inhalation Funckes et al (1963) Infants, children, adult and elderly males and females Inhalation Cavagna et al (1970) Infant males and females Inhalation Cavagna et al (1969) Infants, children, adult males and females, patients hospitalized with silicosis, bronchitis, lead poisoning, liver disease, also pregnant women and sick infants and children Inhalation Uchiyama et al (1967) Children and adults (sex not specified), hospitalized patients, and some with liver disease and leukemia Inhalation Ueda and Nishimura (1967) Adults (sex not specified), hospitalized patients with kidney and liver disease and tuberculosis Inhalation Cervoni et al (1969) Adult male and female patients with intestinal parasites Oral Pena Chavarria et al (1969) Adult male and female patients with intestinal parasites (many debilitated) Oral or reference doses (RfDs) for organophosphate pesticides, including various DDVP products and uses (USEPA-SAP, 1997), and regulatory agencies and other organizations have determined NOELs with this endpoint for acute, short-term (1-7 days) repeat, and more prolonged daily (chronic) exposure scenarios (CDPR, 1997;IPCS, 1990;USEPA, 2000;WHO-JMPR, 1999). Typically, NOELs have been chosen based on the results of a single study that fulfills regulatory requirements for that particular study type, either animal or human.…”
Section: Introductionmentioning
confidence: 99%